MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 16, Pages 203: Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances (Pharmaceuticals)

 
 

29 january 2023 10:03:09

 
Pharmaceuticals, Vol. 16, Pages 203: Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances (Pharmaceuticals)
 


Enterovirus B (EV-B)-related diseases, which can be life threatening in high-risk populations, have been recognized as a serious health problem, but their clinical treatment is largely supportive, and no selective antivirals are available on the market. As their clinical relevance has become more serious, efforts in the field of anti-EV-B inhibitors have greatly increased and many potential antivirals with very high selectivity indexes and promising in vitro activities have been discovered. The scope of this review encompasses recent advances in the discovery of new compounds with anti-viral activity against EV-B, as well as further progress in repurposing drugs to treat these infections. Current progress and future perspectives in drug discovery against EV-Bs are briefly discussed and existing gaps are spotlighted.


 
91 viewsCategory: Medicine, Pharmacology
 
Pharmaceuticals, Vol. 16, Pages 201: Characterization of URB Series Synthetic Cannabinoids by HRMS and UHPLC–MS/MS (Pharmaceuticals)
Pharmaceuticals, Vol. 16, Pages 202: The Chemical Space of Terpenes: Insights from Data Science and AI (Pharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten